Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at RenovoRx Inc fell by 3.22m. Cash Flow from Financing totalled 5.01m or -- of revenues. In addition the company used 10.26m for operations while cash from investing totalled 2.03m.
Cash flow per share | -0.2295 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.3868 |
---|---|
Tangible book value per share | 0.3868 |
More ▼
Balance sheet in USDView more
Current ratio | 9.16 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼